Skip to main content

Table 3 Total HRCT scores in the matched cohort

From: Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis

Matched cohort

PDN group

Non-PDN group

P-value

Total HRCT scores (baseline)

n = 30

n = 30

 

 GGA

13 [10–17]

10 [7–14]

0.033

 Consolidation

2 [0–6]

2 [1–5]

0.593

 Reticulation

11 [7–14]

9 [8–12]

0.592

 Traction bronchiectasis

3 [1–6]

2 [1–5]

0.614

 Honeycombing

8 [7–9]

8 [5–10]

0.779

Total HRCT scores (1-year follow-up)

n = 28

n = 28

 

 GGA

8 [6–10]

11 [7–16]

0.031

 Consolidation

1 [0–4]

6 [2–9]

0.005

 Reticulation

11 [8–14]

14 [11–18]

0.018

 Traction bronchiectasis

3 [0–6]

5 [3–8]

0.077

 Honeycombing

8 [7–11]

9 [8–13]

0.166

1-year change in total scores, n (deterioration/no deterioration)

n = 28

n = 28

 

 GGA

(2/26)

(15/13)

 < 0.001

 Consolidation

(4/24)

(21/7)

 < 0.001

 Reticulation

(12/16)

(27/1)

 < 0.001

 Traction bronchiectasis

(10/18)

(24/4)

0.001

 Honeycombing

(8/20)

(19/9)

0.008

  1. Total HRCT scores at baseline and the 1-year follow-up and the 1-year change in total scores in the matched cohort were calculated. HRCT data were obtained for 28 of the 30 patients at the 1-year follow-up. Values are given as numbers or medians [25th and 75th percentiles]. P-values were obtained from the Wilcoxon signed-rank test and McNemar’s test. GGA ground glass attenuation; HRCT high-resolution computed tomography; PDN prednisolone
  2. The 1-year change in total scores was evaluated dichotomously as indicating deterioration when a total score at the 1-year follow-up was increased from that at baseline or indicating no deterioration when the total score was the same or decreased